Bellevue Funds (Lux) - Bellevue Obesity Solutions I CHF - Accumulating
WKN A0RPSR | ISIN LU0415392835 | Fonds
Fonds
| ISIN | Name | Performance | Volatilität | Sharpe Ratio | ||
|---|---|---|---|---|---|---|
| 1 | LU2441282626 | Janus Henderson Horizon Biotechnology Fund IU2 EUR | +47,03 % | +20,69 % | 2,13 |
|
| 2 | LU2441282899 | Janus Henderson Horizon Biotechnology Fund A2 EUR | +46,82 % | +20,97 % | 2,09 |
|
| 3 | LU1897414568 | J.Henderson H.BioTech.F.IU2 | +41,10 % | +21,16 % | 1,80 |
|
| 4 | LU1897414485 | J.Henderson H.BioTech.F.H2 | +40,92 % | +21,16 % | 1,79 |
|
| 5 | LU1897414303 | J.Henderson H.BioTech.F.A2 | +40,31 % | +21,17 % | 1,76 |
|
| 68 | LU0415392835 | Bellevue Funds (Lux) - Bellevue Obesity Solutions I CHF - Accumulating | +8,83 % | +11,57 % | 0,50 |
|
| 72 | LU1176839154 | Protea Fund - Sectoral Biotech Opportunities Fund IF USD | +10,38 % | +17,07 % | 0,43 |
|
| 73 | LU1176840327 | Protea Fund - Sectoral Biotech Opportunities Fund PF USD | +9,31 % | +17,12 % | 0,37 |
|
| 74 | LU2208649280 | UBS(Lux)E.F.-Biotech(USD)QL a.USD | +9,46 % | +20,07 % | 0,32 |
|
| 75 | LU0400035332 | UBS(Lux)E.F.-Biotech(USD)Q a.USD | +9,25 % | +20,08 % | 0,31 |
|
| 76 | LU0069152568 | UBS (Lux) Equity Fund - Biotech (USD), Anteilsklasse P-acc, USD | +8,14 % | +20,07 % | 0,26 |
|